These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23890285)

  • 1. Rates of false flagging due to statistical artifact in CMS evaluations of transplant programs: results of a stochastic simulation.
    Massie AB; Segev DL
    Am J Transplant; 2013 Aug; 13(8):2044-51. PubMed ID: 23890285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplant wobegon: where all the organs are used, all the patients are transplanted, and all programs are above average.
    Axelrod DA; Snyder J; Kasiske B
    Am J Transplant; 2013 Aug; 13(8):1947-8. PubMed ID: 23890282
    [No Abstract]   [Full Text] [Related]  

  • 3. Poor Performance Flagging Is Associated With Fewer Transplantations at Centers Flagged Multiple Times.
    Beller JP; Hawkins RB; Mehaffey JH; Chancellor WZ; Teaster R; Walters DM; Krupnick AS; Davis RD; Lau CL
    Ann Thorac Surg; 2019 Jun; 107(6):1678-1682. PubMed ID: 30629928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplant center regulations--a mixed blessing? An ASTS Council viewpoint.
    Abecassis MM; Burke R; Cosimi AB; Matas AJ; Merion RM; Millman D; Roberts JP; Klintmalm GB;
    Am J Transplant; 2008 Dec; 8(12):2496-502. PubMed ID: 19032221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMS oversight, OPOs and transplant centers and the law of unintended consequences.
    Howard RJ; Cornell DL; Schold JD
    Clin Transplant; 2009; 23(6):778-83. PubMed ID: 20447183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Implications of Recent and Proposed Changes in the Regulatory Oversight of Solid Organ Transplantation in the United States.
    Kasiske BL; Salkowski N; Wey A; Israni AK; Snyder JJ
    Am J Transplant; 2016 Dec; 16(12):3371-3377. PubMed ID: 27401597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Flagging Criteria of United States Kidney Transplant Center Performance: How to Best Define Outliers?
    Schold JD; Miller CM; Henry ML; Buccini LD; Flechner SM; Goldfarb DA; Poggio ED; Andreoni KA
    Transplantation; 2017 Jun; 101(6):1373-1380. PubMed ID: 27482960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation.
    Abecassis MM; Burke R; Klintmalm GB; Matas AJ; Merion RM; Millman D; Olthoff K; Roberts JP;
    Am J Transplant; 2009 Jun; 9(6):1279-86. PubMed ID: 19392984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant alterations in reported clinical practice associated with increased oversight of organ transplant center performance.
    Schold JD; Arrington CJ; Levine G
    Prog Transplant; 2010 Sep; 20(3):279-87. PubMed ID: 20929114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplant center risk tolerance.
    Johnson SR; Karp SJ; Curry MP; Barugel M; Rodrigue JR; Mandelbrot DA; Rogers CP; Hanto DW
    Clin Transplant; 2012; 26(3):E269-76. PubMed ID: 22686950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cardiovascular comorbidity adjustment on SRTR risk-adjusted cox proportional hazard models of graft survival.
    Pelletier RP; Phillips GS; Rajab A; Pesavento TE; Henry ML
    Transplantation; 2014 Mar; 97(6):686-93. PubMed ID: 24637867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplant center performance profiling: 2005-2011 reports of the Scientific Registry for Transplant Recipients.
    Kettelhut VV; Nayar P
    Prog Transplant; 2013 Jun; 23(2):165-72. PubMed ID: 23782665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do Federal Regulations Have an Impact on Kidney Transplant Outcomes?
    Woodside KJ; Sung RS
    Adv Chronic Kidney Dis; 2016 Sep; 23(5):332-339. PubMed ID: 27742389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplant rejections? Tighter organ-transplant restrictions from the CMS could lead to fewer programs; some are leery of changes based on outcomes.
    Lubell J
    Mod Healthc; 2007 May; 37(21):6-7, 16, 1. PubMed ID: 17824184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney offer acceptance at programs undergoing a Systems Improvement Agreement.
    Bowring MG; Massie AB; Craig-Schapiro R; Segev DL; Nicholas LH
    Am J Transplant; 2018 Sep; 18(9):2182-2188. PubMed ID: 29718565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Centers for Medicare and Medicaid Services' proposed metrics for recertification of organ procurement organizations: Evaluation by the Scientific Registry of Transplant Recipients.
    Snyder JJ; Musgrove D; Zaun D; Wey A; Salkowski N; Rosendale J; Israni AK; Hirose R; Kasiske BL
    Am J Transplant; 2020 Sep; 20(9):2466-2480. PubMed ID: 32157810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status: meeting the regulatory goals of your liver transplant program.
    Batra RK; Mulligan DC
    Curr Opin Organ Transplant; 2021 Apr; 26(2):146-151. PubMed ID: 33650996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accountability in health care--transplant community offers leadership.
    Hamilton TE
    Am J Transplant; 2009 Jun; 9(6):1287-93. PubMed ID: 19459786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient selection and volume in the era surrounding implementation of Medicare conditions of participation for transplant programs.
    White SL; Zinsser DM; Paul M; Levine GN; Shearon T; Ashby VB; Magee JC; Li Y; Leichtman AB
    Health Serv Res; 2015 Apr; 50(2):330-50. PubMed ID: 24838079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of low center performance evaluations and pediatric heart transplant center behavior in the United States.
    Amdani S; Boyle G; Rossano J; Scheel J; Richmond M; Arrigain S; Schold JD
    J Heart Lung Transplant; 2021 Aug; 40(8):831-840. PubMed ID: 34078559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.